NCT04881149View on ClinicalTrials.gov

Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 12, 2021

Primary Completion Date

March 10, 2021

Study Completion Date

March 10, 2021

Conditions
Skin Laxity
Interventions
DEVICE

TempSure treatment

Self-controlled, single-arm study using the TempSure device.

Trial Locations (1)

10022

JUVA Skin & Laser Center, New York

Sponsors

Lead Sponsor

Cynosure, Inc.
All Listed Sponsors
lead

Cynosure, Inc.

INDUSTRY

NCT04881149 - Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks | Biotech Hunter | Biotech Hunter